🇺🇸 FDA
Pipeline program

3-N-butylphthalide

2025-1012

Phase 3 small_molecule active

Quick answer

3-N-butylphthalide for Multiple System Atrophy is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Multiple System Atrophy
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials